KRT14 and neoplasm: Cohorts of tumor-bearing mice were created using primary tumors isolated from a K14-Cre BRCA1f/fp53f/f mouse model (Liu et al., 2007; Rottenberg et al., 2007) and transplanted into syngeneic immune-competent recipients.